Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Venous Thromboembolism | 7 | 2023 | 1883 | 1.340 |
Why?
|
Heparin, Low-Molecular-Weight | 3 | 2023 | 344 | 1.230 |
Why?
|
Kidney Neoplasms | 5 | 2022 | 4278 | 1.070 |
Why?
|
Carcinoma, Renal Cell | 4 | 2022 | 3183 | 1.000 |
Why?
|
Prostatic Neoplasms | 8 | 2024 | 11090 | 0.970 |
Why?
|
Dalteparin | 2 | 2021 | 44 | 0.930 |
Why?
|
Artificial Intelligence | 5 | 2024 | 2661 | 0.870 |
Why?
|
Loperamide | 2 | 2019 | 10 | 0.770 |
Why?
|
Lymphoma, B-Cell | 2 | 2019 | 943 | 0.750 |
Why?
|
Anticoagulants | 7 | 2023 | 4856 | 0.750 |
Why?
|
Antidiarrheals | 2 | 2019 | 46 | 0.750 |
Why?
|
Antigens, CD19 | 4 | 2020 | 442 | 0.730 |
Why?
|
Neoplasms | 11 | 2024 | 22340 | 0.670 |
Why?
|
Antigens, CD20 | 2 | 2017 | 198 | 0.660 |
Why?
|
Immunotherapy, Adoptive | 3 | 2020 | 1504 | 0.640 |
Why?
|
Thrombosis | 3 | 2023 | 2955 | 0.570 |
Why?
|
Femoral Neoplasms | 1 | 2017 | 85 | 0.560 |
Why?
|
Carcinoma, Transitional Cell | 2 | 2022 | 789 | 0.560 |
Why?
|
Linitis Plastica | 1 | 2016 | 1 | 0.560 |
Why?
|
Hematologic Neoplasms | 3 | 2018 | 1926 | 0.550 |
Why?
|
Graft vs Tumor Effect | 1 | 2017 | 70 | 0.540 |
Why?
|
Immune System Diseases | 1 | 2019 | 253 | 0.540 |
Why?
|
Lymphoma, T-Cell | 1 | 2019 | 308 | 0.530 |
Why?
|
Meta-Analysis as Topic | 2 | 2024 | 1366 | 0.520 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2016 | 80 | 0.510 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2016 | 186 | 0.510 |
Why?
|
Acute Coronary Syndrome | 4 | 2018 | 2185 | 0.490 |
Why?
|
Review Literature as Topic | 2 | 2024 | 297 | 0.490 |
Why?
|
Tyrosine | 1 | 2019 | 1427 | 0.480 |
Why?
|
Bed Rest | 1 | 2014 | 82 | 0.470 |
Why?
|
Urinary Bladder Neoplasms | 3 | 2022 | 2176 | 0.460 |
Why?
|
Hematopoietic Stem Cell Transplantation | 5 | 2022 | 5752 | 0.460 |
Why?
|
Lesch-Nyhan Syndrome | 1 | 2014 | 17 | 0.460 |
Why?
|
Dermatitis | 1 | 2016 | 201 | 0.450 |
Why?
|
Nephrectomy | 1 | 2019 | 927 | 0.450 |
Why?
|
Radiculopathy | 1 | 2016 | 204 | 0.440 |
Why?
|
Physicians, Women | 1 | 2020 | 516 | 0.440 |
Why?
|
Randomized Controlled Trials as Topic | 15 | 2022 | 10380 | 0.430 |
Why?
|
Renal Artery Obstruction | 1 | 2014 | 216 | 0.420 |
Why?
|
Spinal Stenosis | 1 | 2016 | 259 | 0.420 |
Why?
|
Vitamin K 2 | 1 | 2012 | 43 | 0.420 |
Why?
|
Humans | 115 | 2024 | 765926 | 0.420 |
Why?
|
Government | 1 | 2013 | 161 | 0.410 |
Why?
|
Liver Neoplasms | 5 | 2024 | 4349 | 0.400 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 483 | 0.400 |
Why?
|
Arrhythmias, Cardiac | 3 | 2019 | 2255 | 0.390 |
Why?
|
Recombinant Fusion Proteins | 2 | 2017 | 3733 | 0.390 |
Why?
|
Hemorrhage | 9 | 2023 | 3466 | 0.380 |
Why?
|
Access to Information | 2 | 2016 | 317 | 0.380 |
Why?
|
Coronary Occlusion | 1 | 2014 | 284 | 0.370 |
Why?
|
T-Lymphocytes | 3 | 2017 | 10256 | 0.370 |
Why?
|
Foramen Ovale, Patent | 1 | 2013 | 209 | 0.360 |
Why?
|
Consumer Health Information | 1 | 2013 | 215 | 0.360 |
Why?
|
Human Rights | 1 | 2013 | 312 | 0.350 |
Why?
|
Multiple Myeloma | 4 | 2022 | 5189 | 0.350 |
Why?
|
Troponin | 1 | 2014 | 532 | 0.350 |
Why?
|
Carcinoma, Hepatocellular | 3 | 2021 | 2325 | 0.320 |
Why?
|
Blood Coagulation | 1 | 2014 | 1171 | 0.300 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2019 | 3498 | 0.300 |
Why?
|
Thromboembolism | 1 | 2014 | 1001 | 0.300 |
Why?
|
Cardiovascular Agents | 1 | 2014 | 848 | 0.290 |
Why?
|
Lutetium | 2 | 2024 | 38 | 0.290 |
Why?
|
Vitamins | 2 | 2014 | 1631 | 0.290 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2017 | 2570 | 0.290 |
Why?
|
Heterocyclic Compounds, 1-Ring | 2 | 2024 | 68 | 0.290 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 8 | 2022 | 11858 | 0.280 |
Why?
|
Syncope | 3 | 2015 | 431 | 0.280 |
Why?
|
B-Lymphocytes | 2 | 2017 | 4782 | 0.280 |
Why?
|
Chest Pain | 1 | 2014 | 1102 | 0.270 |
Why?
|
Male | 44 | 2024 | 363815 | 0.270 |
Why?
|
Minority Groups | 3 | 2023 | 1208 | 0.260 |
Why?
|
Myocarditis | 1 | 2014 | 803 | 0.260 |
Why?
|
Stomach Neoplasms | 1 | 2016 | 1469 | 0.260 |
Why?
|
Death, Sudden, Cardiac | 1 | 2014 | 1568 | 0.260 |
Why?
|
Coronary Thrombosis | 3 | 2018 | 440 | 0.250 |
Why?
|
Dipeptides | 2 | 2024 | 386 | 0.250 |
Why?
|
Vascular Surgical Procedures | 1 | 2014 | 1506 | 0.250 |
Why?
|
Interleukin-12 | 2 | 2018 | 581 | 0.240 |
Why?
|
Androgen Antagonists | 3 | 2023 | 1411 | 0.240 |
Why?
|
Arthritis, Psoriatic | 2 | 2018 | 218 | 0.240 |
Why?
|
Cisplatin | 2 | 2022 | 1654 | 0.240 |
Why?
|
Anticholesteremic Agents | 2 | 2022 | 970 | 0.240 |
Why?
|
Transplantation, Autologous | 5 | 2022 | 2125 | 0.240 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2016 | 1643 | 0.240 |
Why?
|
Defibrillators, Implantable | 1 | 2014 | 1497 | 0.230 |
Why?
|
Recurrence | 6 | 2022 | 8492 | 0.230 |
Why?
|
Stroke | 6 | 2022 | 9739 | 0.220 |
Why?
|
Graft vs Host Disease | 1 | 2017 | 3079 | 0.220 |
Why?
|
Disease-Free Survival | 3 | 2022 | 6838 | 0.220 |
Why?
|
Administration, Oral | 3 | 2021 | 4016 | 0.220 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2024 | 90 | 0.220 |
Why?
|
Pyridones | 2 | 2020 | 816 | 0.220 |
Why?
|
Treatment Outcome | 22 | 2024 | 65194 | 0.220 |
Why?
|
Myocardial Infarction | 5 | 2022 | 11508 | 0.210 |
Why?
|
Castration | 1 | 2023 | 149 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2021 | 9373 | 0.210 |
Why?
|
Cardiovascular Diseases | 8 | 2022 | 15645 | 0.200 |
Why?
|
Carbolines | 1 | 2024 | 288 | 0.200 |
Why?
|
Influenza Vaccines | 2 | 2020 | 780 | 0.200 |
Why?
|
Aged | 23 | 2024 | 171163 | 0.190 |
Why?
|
Interleukin-17 | 2 | 2018 | 921 | 0.190 |
Why?
|
Chronic Disease | 1 | 2016 | 9351 | 0.190 |
Why?
|
Warfarin | 2 | 2023 | 1494 | 0.190 |
Why?
|
Chemoprevention | 2 | 2014 | 327 | 0.190 |
Why?
|
Antihypertensive Agents | 3 | 2015 | 2028 | 0.180 |
Why?
|
Waiting Lists | 4 | 2019 | 779 | 0.180 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2024 | 340 | 0.170 |
Why?
|
Stroke Volume | 1 | 2014 | 5595 | 0.170 |
Why?
|
Liver Transplantation | 3 | 2019 | 2418 | 0.170 |
Why?
|
Clinical Trials as Topic | 5 | 2017 | 8037 | 0.170 |
Why?
|
Transplantation, Homologous | 3 | 2018 | 4859 | 0.170 |
Why?
|
Risk Assessment | 9 | 2021 | 24275 | 0.170 |
Why?
|
Psoriasis | 2 | 2018 | 922 | 0.170 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2021 | 153 | 0.170 |
Why?
|
Antigens, Surface | 1 | 2024 | 1616 | 0.170 |
Why?
|
Tissue Donors | 3 | 2019 | 2392 | 0.170 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2020 | 1559 | 0.160 |
Why?
|
Deoxycytidine | 2 | 2022 | 886 | 0.160 |
Why?
|
IgA Deficiency | 1 | 2019 | 39 | 0.160 |
Why?
|
Muscles | 2 | 2022 | 1577 | 0.160 |
Why?
|
Vinblastine | 1 | 2020 | 483 | 0.160 |
Why?
|
BRCA2 Protein | 1 | 2023 | 802 | 0.160 |
Why?
|
Pyrazoles | 2 | 2020 | 2031 | 0.150 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2021 | 637 | 0.150 |
Why?
|
Atherosclerosis | 1 | 2014 | 3419 | 0.150 |
Why?
|
Adiposis Dolorosa | 1 | 2018 | 12 | 0.150 |
Why?
|
Azotemia | 1 | 2017 | 8 | 0.150 |
Why?
|
Coronary Artery Disease | 2 | 2016 | 6544 | 0.150 |
Why?
|
Remission Induction | 3 | 2020 | 2413 | 0.140 |
Why?
|
Bibliometrics | 2 | 2018 | 356 | 0.140 |
Why?
|
Hot Temperature | 2 | 2014 | 1433 | 0.140 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1759 | 0.140 |
Why?
|
Receptors, Antigen | 1 | 2017 | 51 | 0.140 |
Why?
|
Dermatologic Agents | 2 | 2019 | 314 | 0.140 |
Why?
|
Retrospective Studies | 15 | 2024 | 81537 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1536 | 0.140 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2022 | 3249 | 0.140 |
Why?
|
Amphetamine | 1 | 2018 | 222 | 0.140 |
Why?
|
Antiviral Agents | 2 | 2020 | 3053 | 0.130 |
Why?
|
IgG Deficiency | 1 | 2016 | 28 | 0.130 |
Why?
|
Opportunistic Infections | 1 | 2019 | 376 | 0.130 |
Why?
|
Interleukin-23 | 1 | 2018 | 202 | 0.130 |
Why?
|
Female | 27 | 2024 | 396141 | 0.130 |
Why?
|
Natural Language Processing | 2 | 2022 | 1198 | 0.130 |
Why?
|
Middle Aged | 23 | 2024 | 223016 | 0.130 |
Why?
|
Least-Squares Analysis | 1 | 2016 | 368 | 0.130 |
Why?
|
Back Pain | 1 | 2020 | 546 | 0.130 |
Why?
|
Purpura, Thrombotic Thrombocytopenic | 1 | 2017 | 132 | 0.130 |
Why?
|
Desert Climate | 1 | 2015 | 12 | 0.130 |
Why?
|
Health Expenditures | 2 | 2020 | 2388 | 0.130 |
Why?
|
Androgens | 1 | 2023 | 1278 | 0.130 |
Why?
|
Pulmonary Embolism | 2 | 2021 | 2596 | 0.120 |
Why?
|
Survival Analysis | 5 | 2020 | 10086 | 0.120 |
Why?
|
Magnetic Resonance Imaging | 4 | 2016 | 36547 | 0.120 |
Why?
|
Immobility Response, Tonic | 1 | 2014 | 13 | 0.120 |
Why?
|
Antigens, Differentiation | 1 | 2018 | 919 | 0.120 |
Why?
|
Physical Examination | 1 | 2021 | 1263 | 0.120 |
Why?
|
Databases, Genetic | 1 | 2021 | 1756 | 0.120 |
Why?
|
Prodrugs | 1 | 2017 | 274 | 0.120 |
Why?
|
Interleukins | 1 | 2019 | 789 | 0.120 |
Why?
|
Aspirin | 2 | 2016 | 3135 | 0.120 |
Why?
|
Breast | 1 | 2023 | 1950 | 0.120 |
Why?
|
Hypercalcemia | 1 | 2017 | 425 | 0.120 |
Why?
|
Sternum | 1 | 2015 | 177 | 0.120 |
Why?
|
Protein Kinase Inhibitors | 2 | 2021 | 5691 | 0.120 |
Why?
|
Avitaminosis | 1 | 2014 | 35 | 0.110 |
Why?
|
Sternotomy | 1 | 2015 | 134 | 0.110 |
Why?
|
Injections, Epidural | 1 | 2016 | 204 | 0.110 |
Why?
|
Hepatitis B virus | 1 | 2018 | 532 | 0.110 |
Why?
|
Radiopharmaceuticals | 1 | 2024 | 2701 | 0.110 |
Why?
|
Financial Management | 1 | 2015 | 161 | 0.110 |
Why?
|
Dietary Supplements | 2 | 2019 | 3427 | 0.110 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11196 | 0.110 |
Why?
|
Methotrexate | 1 | 2020 | 1719 | 0.110 |
Why?
|
Doxorubicin | 1 | 2020 | 2226 | 0.110 |
Why?
|
Fractures, Ununited | 1 | 2015 | 176 | 0.110 |
Why?
|
United States | 11 | 2022 | 72909 | 0.110 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12973 | 0.110 |
Why?
|
Abdominal Fat | 1 | 2015 | 217 | 0.110 |
Why?
|
Prognosis | 4 | 2024 | 29890 | 0.110 |
Why?
|
Confidence Intervals | 2 | 2024 | 2915 | 0.110 |
Why?
|
Antibodies, Bispecific | 1 | 2016 | 203 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2019 | 9239 | 0.110 |
Why?
|
Arthralgia | 1 | 2017 | 459 | 0.110 |
Why?
|
Cell Count | 1 | 2017 | 1823 | 0.110 |
Why?
|
Glomerulonephritis, Membranous | 1 | 2014 | 86 | 0.110 |
Why?
|
Internal Medicine | 1 | 2020 | 1064 | 0.110 |
Why?
|
Amnion | 1 | 2014 | 204 | 0.110 |
Why?
|
Combined Modality Therapy | 3 | 2021 | 8522 | 0.110 |
Why?
|
Hashimoto Disease | 1 | 2014 | 108 | 0.110 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2023 | 5379 | 0.110 |
Why?
|
Photosensitizing Agents | 1 | 2017 | 626 | 0.100 |
Why?
|
Liver Failure | 1 | 2015 | 252 | 0.100 |
Why?
|
Publishing | 1 | 2020 | 836 | 0.100 |
Why?
|
Salvage Therapy | 2 | 2017 | 1272 | 0.100 |
Why?
|
Antirheumatic Agents | 2 | 2019 | 1378 | 0.100 |
Why?
|
Endosonography | 1 | 2016 | 626 | 0.100 |
Why?
|
Rheumatic Diseases | 1 | 2019 | 657 | 0.100 |
Why?
|
Biomedical Research | 2 | 2020 | 3458 | 0.100 |
Why?
|
Brachytherapy | 1 | 2020 | 1218 | 0.100 |
Why?
|
Oligopeptides | 1 | 2018 | 1193 | 0.100 |
Why?
|
Hepatitis B | 1 | 2018 | 709 | 0.100 |
Why?
|
Propensity Score | 2 | 2018 | 1971 | 0.100 |
Why?
|
Hepatic Encephalopathy | 1 | 2013 | 143 | 0.100 |
Why?
|
Seasons | 2 | 2015 | 1522 | 0.100 |
Why?
|
Hypotension, Orthostatic | 1 | 2015 | 258 | 0.100 |
Why?
|
Drug Administration Schedule | 5 | 2018 | 4851 | 0.100 |
Why?
|
Electronic Health Records | 3 | 2024 | 4863 | 0.100 |
Why?
|
Drug Resistance | 1 | 2018 | 1588 | 0.100 |
Why?
|
Periodicals as Topic | 3 | 2020 | 1463 | 0.100 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2076 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1415 | 0.100 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2016 | 667 | 0.100 |
Why?
|
Bioprosthesis | 1 | 2016 | 592 | 0.090 |
Why?
|
Drug-Eluting Stents | 2 | 2015 | 680 | 0.090 |
Why?
|
Fatty Liver | 1 | 2018 | 810 | 0.090 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2018 | 949 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2020 | 1225 | 0.090 |
Why?
|
Research Support as Topic | 1 | 2015 | 697 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3599 | 0.090 |
Why?
|
Pancreatic Neoplasms | 2 | 2020 | 5450 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2017 | 826 | 0.090 |
Why?
|
Conflict of Interest | 1 | 2015 | 556 | 0.090 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2019 | 3542 | 0.090 |
Why?
|
Heart Septal Defects, Atrial | 1 | 2013 | 452 | 0.090 |
Why?
|
Endometrial Neoplasms | 1 | 2020 | 1378 | 0.090 |
Why?
|
Leadership | 1 | 2020 | 1393 | 0.090 |
Why?
|
End Stage Liver Disease | 1 | 2015 | 369 | 0.090 |
Why?
|
Hypertension | 3 | 2015 | 8616 | 0.090 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2015 | 504 | 0.090 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2016 | 889 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 2 | 2016 | 3682 | 0.090 |
Why?
|
Tissue and Organ Procurement | 2 | 2015 | 988 | 0.080 |
Why?
|
Pacemaker, Artificial | 1 | 2015 | 829 | 0.080 |
Why?
|
Sex Characteristics | 1 | 2020 | 2645 | 0.080 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59496 | 0.080 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2018 | 2769 | 0.080 |
Why?
|
Education, Medical | 1 | 2021 | 1744 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2004 | 0.080 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2726 | 0.080 |
Why?
|
Morbidity | 1 | 2014 | 1752 | 0.080 |
Why?
|
Knee Joint | 1 | 2017 | 1656 | 0.080 |
Why?
|
Skin Diseases | 1 | 2017 | 1083 | 0.080 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2016 | 1093 | 0.080 |
Why?
|
Lymphatic Metastasis | 1 | 2016 | 2885 | 0.080 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2016 | 1374 | 0.080 |
Why?
|
Dermatology | 1 | 2018 | 905 | 0.080 |
Why?
|
Heart Valve Diseases | 1 | 2016 | 1029 | 0.080 |
Why?
|
Cicatrix | 1 | 2014 | 796 | 0.070 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2017 | 1485 | 0.070 |
Why?
|
Antineoplastic Agents | 4 | 2024 | 13631 | 0.070 |
Why?
|
Lymphoma | 1 | 2017 | 1896 | 0.070 |
Why?
|
Secondary Prevention | 1 | 2014 | 1470 | 0.070 |
Why?
|
Journal Impact Factor | 2 | 2020 | 157 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2018 | 3225 | 0.070 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6542 | 0.070 |
Why?
|
Heart Valve Prosthesis | 1 | 2016 | 1464 | 0.070 |
Why?
|
Survivors | 1 | 2018 | 2373 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13446 | 0.070 |
Why?
|
Bone Marrow | 1 | 2017 | 2916 | 0.070 |
Why?
|
Heparin | 1 | 2014 | 1632 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1881 | 0.070 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12529 | 0.070 |
Why?
|
Immunotherapy | 2 | 2020 | 4746 | 0.070 |
Why?
|
Cardiomyopathy, Hypertrophic | 1 | 2016 | 1338 | 0.070 |
Why?
|
Lumbar Vertebrae | 1 | 2016 | 1878 | 0.070 |
Why?
|
Health Behavior | 1 | 2018 | 2649 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2013 | 1318 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2014 | 996 | 0.070 |
Why?
|
Aortic Valve | 1 | 2016 | 1964 | 0.060 |
Why?
|
Adult | 15 | 2022 | 223088 | 0.060 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2016 | 1563 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6766 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2023 | 21069 | 0.060 |
Why?
|
Primary Health Care | 2 | 2020 | 4736 | 0.060 |
Why?
|
Clinical Competence | 1 | 2021 | 4855 | 0.060 |
Why?
|
Disabled Persons | 1 | 2014 | 1208 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2020 | 26282 | 0.060 |
Why?
|
Organ Transplantation | 1 | 2015 | 1172 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2015 | 3094 | 0.060 |
Why?
|
Animals | 7 | 2018 | 168735 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2017 | 3075 | 0.060 |
Why?
|
Stents | 1 | 2015 | 3191 | 0.060 |
Why?
|
Point-of-Care Systems | 2 | 2024 | 1218 | 0.050 |
Why?
|
Acute Disease | 1 | 2014 | 7236 | 0.050 |
Why?
|
Myocardium | 1 | 2016 | 4764 | 0.050 |
Why?
|
Electric Power Supplies | 1 | 2023 | 94 | 0.050 |
Why?
|
Risk Factors | 10 | 2022 | 74850 | 0.050 |
Why?
|
Liver Cirrhosis | 1 | 2013 | 1961 | 0.050 |
Why?
|
Cholesterol, LDL | 2 | 2022 | 2395 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3109 | 0.050 |
Why?
|
Salivary Glands | 1 | 2024 | 231 | 0.050 |
Why?
|
Tomography, Optical Coherence | 1 | 2015 | 2876 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3231 | 0.050 |
Why?
|
Radioisotopes | 1 | 2024 | 498 | 0.050 |
Why?
|
Case-Control Studies | 2 | 2018 | 22228 | 0.050 |
Why?
|
Healthcare Disparities | 2 | 2015 | 3407 | 0.050 |
Why?
|
Young Adult | 6 | 2020 | 59857 | 0.050 |
Why?
|
Pain | 1 | 2017 | 5077 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7559 | 0.050 |
Why?
|
Carcinoma, Small Cell | 1 | 2024 | 420 | 0.050 |
Why?
|
Comorbidity | 1 | 2016 | 10575 | 0.050 |
Why?
|
Mutation | 2 | 2023 | 30192 | 0.050 |
Why?
|
Electrocardiography | 1 | 2015 | 6409 | 0.050 |
Why?
|
Quality of Life | 1 | 2023 | 13463 | 0.050 |
Why?
|
Palliative Care | 1 | 2016 | 3640 | 0.050 |
Why?
|
Time Factors | 6 | 2019 | 40097 | 0.050 |
Why?
|
Retinoblastoma Binding Proteins | 1 | 2021 | 101 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2017 | 5128 | 0.040 |
Why?
|
Depression | 1 | 2020 | 8223 | 0.040 |
Why?
|
Minnesota | 1 | 2020 | 339 | 0.040 |
Why?
|
Stem Cell Transplantation | 2 | 2019 | 1600 | 0.040 |
Why?
|
Spondylosis | 1 | 2020 | 84 | 0.040 |
Why?
|
Molecular Sequence Annotation | 1 | 2021 | 525 | 0.040 |
Why?
|
Databases, Factual | 3 | 2020 | 8060 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2016 | 2111 | 0.040 |
Why?
|
Adenosine Monophosphate | 1 | 2020 | 232 | 0.040 |
Why?
|
Registries | 1 | 2015 | 8346 | 0.040 |
Why?
|
Substance-Related Disorders | 1 | 2015 | 4418 | 0.040 |
Why?
|
Ritonavir | 1 | 2020 | 331 | 0.040 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.040 |
Why?
|
Mastectomy, Segmental | 1 | 2023 | 964 | 0.040 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2023 | 1777 | 0.040 |
Why?
|
Aromatase Inhibitors | 1 | 2022 | 518 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2022 | 904 | 0.040 |
Why?
|
Alanine | 1 | 2020 | 613 | 0.040 |
Why?
|
Hormones | 1 | 2021 | 865 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18074 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7423 | 0.030 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1060 | 0.030 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2018 | 212 | 0.030 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39228 | 0.030 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 831 | 0.030 |
Why?
|
Predictive Value of Tests | 3 | 2019 | 15401 | 0.030 |
Why?
|
Patient Care | 1 | 2022 | 628 | 0.030 |
Why?
|
Keratosis, Actinic | 1 | 2017 | 71 | 0.030 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2020 | 878 | 0.030 |
Why?
|
Hydroxychloroquine | 1 | 2020 | 429 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2823 | 0.030 |
Why?
|
Standard of Care | 1 | 2020 | 568 | 0.030 |
Why?
|
Atrial Fibrillation | 1 | 2014 | 5186 | 0.030 |
Why?
|
Evidence-Based Medicine | 2 | 2020 | 3690 | 0.030 |
Why?
|
PTEN Phosphohydrolase | 1 | 2021 | 1117 | 0.030 |
Why?
|
Retreatment | 1 | 2017 | 598 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2020 | 1009 | 0.030 |
Why?
|
Arizona | 1 | 2015 | 108 | 0.030 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2017 | 168 | 0.030 |
Why?
|
Fractures, Comminuted | 1 | 2015 | 58 | 0.030 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2022 | 1127 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2024 | 2463 | 0.030 |
Why?
|
Anesthesia, Local | 1 | 2017 | 276 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 301 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23597 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5889 | 0.030 |
Why?
|
Gastrointestinal Agents | 1 | 2019 | 511 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2017 | 655 | 0.030 |
Why?
|
Immunocompromised Host | 1 | 2019 | 865 | 0.030 |
Why?
|
China | 1 | 2020 | 2383 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9656 | 0.030 |
Why?
|
Drug Combinations | 1 | 2020 | 2075 | 0.030 |
Why?
|
Indoles | 1 | 2022 | 1833 | 0.030 |
Why?
|
Dehydration | 1 | 2015 | 215 | 0.030 |
Why?
|
Intention to Treat Analysis | 1 | 2015 | 418 | 0.030 |
Why?
|
Prednisolone | 1 | 2014 | 323 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12059 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2023 | 4882 | 0.030 |
Why?
|
Azathioprine | 1 | 2014 | 354 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2353 | 0.030 |
Why?
|
Repressor Proteins | 1 | 2023 | 2969 | 0.030 |
Why?
|
Geography | 1 | 2015 | 651 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20133 | 0.030 |
Why?
|
Thalidomide | 1 | 2018 | 886 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2021 | 2050 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5333 | 0.020 |
Why?
|
Glomerulonephritis | 1 | 2014 | 331 | 0.020 |
Why?
|
Fracture Healing | 1 | 2015 | 448 | 0.020 |
Why?
|
History, 21st Century | 1 | 2018 | 1572 | 0.020 |
Why?
|
Bone Plates | 1 | 2015 | 468 | 0.020 |
Why?
|
Phagocytosis | 1 | 2018 | 1517 | 0.020 |
Why?
|
Medical Oncology | 1 | 2024 | 2339 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2014 | 15802 | 0.020 |
Why?
|
Carcinoma, Basal Cell | 1 | 2017 | 565 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2021 | 1894 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21513 | 0.020 |
Why?
|
Receptor, erbB-2 | 1 | 2022 | 2592 | 0.020 |
Why?
|
Metals | 1 | 2015 | 709 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15878 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2020 | 2155 | 0.020 |
Why?
|
Cohort Studies | 1 | 2013 | 41680 | 0.020 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2021 | 2945 | 0.020 |
Why?
|
Thyroxine | 1 | 2014 | 665 | 0.020 |
Why?
|
Pilot Projects | 1 | 2024 | 8724 | 0.020 |
Why?
|
Ischemic Attack, Transient | 1 | 2016 | 871 | 0.020 |
Why?
|
Long QT Syndrome | 1 | 2015 | 474 | 0.020 |
Why?
|
History, 20th Century | 1 | 2018 | 2760 | 0.020 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2895 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2015 | 1835 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2018 | 2740 | 0.020 |
Why?
|
Nerve Block | 1 | 2017 | 715 | 0.020 |
Why?
|
Dexamethasone | 1 | 2018 | 1962 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3430 | 0.020 |
Why?
|
Transplantation Conditioning | 1 | 2017 | 1635 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1949 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15828 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2022 | 3661 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2023 | 5782 | 0.020 |
Why?
|
Cholesterol | 1 | 2018 | 2902 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6204 | 0.020 |
Why?
|
Perioperative Care | 1 | 2016 | 1042 | 0.020 |
Why?
|
Cause of Death | 1 | 2019 | 3715 | 0.020 |
Why?
|
Cyclophosphamide | 1 | 2014 | 2232 | 0.020 |
Why?
|
Information Dissemination | 1 | 2016 | 1142 | 0.020 |
Why?
|
Echocardiography | 1 | 2021 | 5040 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2022 | 12417 | 0.020 |
Why?
|
Equipment Design | 1 | 2015 | 3490 | 0.020 |
Why?
|
Curriculum | 1 | 2021 | 3784 | 0.020 |
Why?
|
Vaccination | 1 | 2019 | 3430 | 0.020 |
Why?
|
Pain Measurement | 1 | 2017 | 3558 | 0.020 |
Why?
|
Surgical Flaps | 1 | 2015 | 1678 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1319 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2015 | 2188 | 0.020 |
Why?
|
Disease Progression | 1 | 2023 | 13614 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12822 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10727 | 0.020 |
Why?
|
Genomics | 1 | 2021 | 5925 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2016 | 5500 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 2018 | 4041 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5873 | 0.010 |
Why?
|
Coronary Disease | 1 | 2019 | 5919 | 0.010 |
Why?
|
Wound Healing | 1 | 2015 | 2794 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3230 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13273 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9505 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2017 | 4044 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5936 | 0.010 |
Why?
|
Smoking | 1 | 2018 | 9082 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8721 | 0.010 |
Why?
|
Body Mass Index | 1 | 2018 | 13042 | 0.010 |
Why?
|
Diet | 1 | 2018 | 8087 | 0.010 |
Why?
|
Adolescent | 2 | 2020 | 88811 | 0.010 |
Why?
|
Age Factors | 1 | 2013 | 18382 | 0.010 |
Why?
|
Aging | 1 | 2014 | 8725 | 0.010 |
Why?
|
Inflammation | 1 | 2014 | 10843 | 0.010 |
Why?
|